Global Spinal Muscular Atrophy Treatment Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Spinal Muscular Atrophy Treatment market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Spinal Muscular Atrophy Treatment market are covered in Chapter 9:
Catalyst Pharmaceuticals
UW Health
Cytokinetics, Inc.
Genentech, Inc
Chugai Pharmaceutical
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche AG
PTC Therapeutics
Regeneron Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
PerkinElmer, Inc.
Novo Nordisk A/S
Novartis International AG
Genzyme Corporation
Salarius Pharmaceuticals, Inc.
Astellas Pharma Inc.
Isis Pharmaceuticals, Inc.
Cure SMA
AstraZeneca PLC
Natera, Inc
Biogen Inc.
Takeda Pharmaceutical Company Limited
Pfizer Inc.
In Chapter 5 and Chapter 7.3, based on types, the Spinal Muscular Atrophy Treatment market from 2017 to 2027 is primarily split into:
Oral
Intrathecal
In Chapter 6 and Chapter 7.4, based on applications, the Spinal Muscular Atrophy Treatment market from 2017 to 2027 covers:
Gene Replacement Therapy
Drug Therapy
Other Procedures
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Spinal Muscular Atrophy Treatment market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Spinal Muscular Atrophy Treatment Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Spinal Muscular Atrophy Treatment market are covered in Chapter 9:
Catalyst Pharmaceuticals
UW Health
Cytokinetics, Inc.
Genentech, Inc
Chugai Pharmaceutical
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche AG
PTC Therapeutics
Regeneron Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
PerkinElmer, Inc.
Novo Nordisk A/S
Novartis International AG
Genzyme Corporation
Salarius Pharmaceuticals, Inc.
Astellas Pharma Inc.
Isis Pharmaceuticals, Inc.
Cure SMA
AstraZeneca PLC
Natera, Inc
Biogen Inc.
Takeda Pharmaceutical Company Limited
Pfizer Inc.
In Chapter 5 and Chapter 7.3, based on types, the Spinal Muscular Atrophy Treatment market from 2017 to 2027 is primarily split into:
Oral
Intrathecal
In Chapter 6 and Chapter 7.4, based on applications, the Spinal Muscular Atrophy Treatment market from 2017 to 2027 covers:
Gene Replacement Therapy
Drug Therapy
Other Procedures
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Spinal Muscular Atrophy Treatment market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Spinal Muscular Atrophy Treatment Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 SPINAL MUSCULAR ATROPHY TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Spinal Muscular Atrophy Treatment Market
1.2 Spinal Muscular Atrophy Treatment Market Segment by Type
1.2.1 Global Spinal Muscular Atrophy Treatment Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Spinal Muscular Atrophy Treatment Market Segment by Application
1.3.1 Spinal Muscular Atrophy Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Spinal Muscular Atrophy Treatment Market, Region Wise (2017-2027)
1.4.1 Global Spinal Muscular Atrophy Treatment Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.3 Europe Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.4 China Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.5 Japan Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.6 India Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.8 Latin America Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.5 Global Market Size of Spinal Muscular Atrophy Treatment (2017-2027)
1.5.1 Global Spinal Muscular Atrophy Treatment Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Spinal Muscular Atrophy Treatment Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Spinal Muscular Atrophy Treatment Market
2 INDUSTRY OUTLOOK
2.1 Spinal Muscular Atrophy Treatment Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Spinal Muscular Atrophy Treatment Market Drivers Analysis
2.4 Spinal Muscular Atrophy Treatment Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Spinal Muscular Atrophy Treatment Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Spinal Muscular Atrophy Treatment Industry Development
3 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET LANDSCAPE BY PLAYER
3.1 Global Spinal Muscular Atrophy Treatment Sales Volume and Share by Player (2017-2022)
3.2 Global Spinal Muscular Atrophy Treatment Revenue and Market Share by Player (2017-2022)
3.3 Global Spinal Muscular Atrophy Treatment Average Price by Player (2017-2022)
3.4 Global Spinal Muscular Atrophy Treatment Gross Margin by Player (2017-2022)
3.5 Spinal Muscular Atrophy Treatment Market Competitive Situation and Trends
3.5.1 Spinal Muscular Atrophy Treatment Market Concentration Rate
3.5.2 Spinal Muscular Atrophy Treatment Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Spinal Muscular Atrophy Treatment Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Spinal Muscular Atrophy Treatment Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Spinal Muscular Atrophy Treatment Market Under COVID-19
4.5 Europe Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Spinal Muscular Atrophy Treatment Market Under COVID-19
4.6 China Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Spinal Muscular Atrophy Treatment Market Under COVID-19
4.7 Japan Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Spinal Muscular Atrophy Treatment Market Under COVID-19
4.8 India Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Spinal Muscular Atrophy Treatment Market Under COVID-19
4.9 Southeast Asia Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Spinal Muscular Atrophy Treatment Market Under COVID-19
4.10 Latin America Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Spinal Muscular Atrophy Treatment Market Under COVID-19
4.11 Middle East and Africa Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Under COVID-19
5 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Spinal Muscular Atrophy Treatment Sales Volume and Market Share by Type (2017-2022)
5.2 Global Spinal Muscular Atrophy Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Spinal Muscular Atrophy Treatment Price by Type (2017-2022)
5.4 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue and Growth Rate of Oral (2017-2022)
5.4.2 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue and Growth Rate of Intrathecal (2017-2022)
6 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Global Spinal Muscular Atrophy Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Spinal Muscular Atrophy Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Gene Replacement Therapy (2017-2022)
6.3.2 Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Drug Therapy (2017-2022)
6.3.3 Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Other Procedures (2017-2022)
7 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET FORECAST (2022-2027)
7.1 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Spinal Muscular Atrophy Treatment Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Spinal Muscular Atrophy Treatment Price and Trend Forecast (2022-2027)
7.2 Global Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Spinal Muscular Atrophy Treatment Revenue and Growth Rate of Oral (2022-2027)
7.3.2 Global Spinal Muscular Atrophy Treatment Revenue and Growth Rate of Intrathecal (2022-2027)
7.4 Global Spinal Muscular Atrophy Treatment Consumption Forecast by Application (2022-2027)
7.4.1 Global Spinal Muscular Atrophy Treatment Consumption Value and Growth Rate of Gene Replacement Therapy(2022-2027)
7.4.2 Global Spinal Muscular Atrophy Treatment Consumption Value and Growth Rate of Drug Therapy(2022-2027)
7.4.3 Global Spinal Muscular Atrophy Treatment Consumption Value and Growth Rate of Other Procedures(2022-2027)
7.5 Spinal Muscular Atrophy Treatment Market Forecast Under COVID-19
8 SPINAL MUSCULAR ATROPHY TREATMENT MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Spinal Muscular Atrophy Treatment Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Spinal Muscular Atrophy Treatment Analysis
8.6 Major Downstream Buyers of Spinal Muscular Atrophy Treatment Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Spinal Muscular Atrophy Treatment Industry
9 PLAYERS PROFILES
9.1 Catalyst Pharmaceuticals
9.1.1 Catalyst Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.1.3 Catalyst Pharmaceuticals Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 UW Health
9.2.1 UW Health Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.2.3 UW Health Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Cytokinetics, Inc.
9.3.1 Cytokinetics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.3.3 Cytokinetics, Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Genentech, Inc
9.4.1 Genentech, Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.4.3 Genentech, Inc Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Chugai Pharmaceutical
9.5.1 Chugai Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.5.3 Chugai Pharmaceutical Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Boehringer Ingelheim GmbH
9.6.1 Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.6.3 Boehringer Ingelheim GmbH Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 F. Hoffmann-La Roche AG
9.7.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.7.3 F. Hoffmann-La Roche AG Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 PTC Therapeutics
9.8.1 PTC Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.8.3 PTC Therapeutics Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Regeneron Pharmaceuticals, Inc.
9.9.1 Regeneron Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.9.3 Regeneron Pharmaceuticals, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Ionis Pharmaceuticals, Inc.
9.10.1 Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.10.3 Ionis Pharmaceuticals, Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 PerkinElmer, Inc.
9.11.1 PerkinElmer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.11.3 PerkinElmer, Inc. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Novo Nordisk A/S
9.12.1 Novo Nordisk A/S Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.12.3 Novo Nordisk A/S Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Novartis International AG
9.13.1 Novartis International AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.13.3 Novartis International AG Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Genzyme Corporation
9.14.1 Genzyme Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.14.3 Genzyme Corporation Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Salarius Pharmaceuticals, Inc.
9.15.1 Salarius Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.15.3 Salarius Pharmaceuticals, Inc. Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Astellas Pharma Inc.
9.16.1 Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.16.3 Astellas Pharma Inc. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Isis Pharmaceuticals, Inc.
9.17.1 Isis Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.17.3 Isis Pharmaceuticals, Inc. Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Cure SMA
9.18.1 Cure SMA Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.18.3 Cure SMA Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 AstraZeneca PLC
9.19.1 AstraZeneca PLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.19.3 AstraZeneca PLC Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Natera, Inc
9.20.1 Natera, Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.20.3 Natera, Inc Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 Biogen Inc.
9.21.1 Biogen Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.21.3 Biogen Inc. Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
9.22 Takeda Pharmaceutical Company Limited
9.22.1 Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.22.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.22.3 Takeda Pharmaceutical Company Limited Market Performance (2017-2022)
9.22.4 Recent Development
9.22.5 SWOT Analysis
9.23 Pfizer Inc.
9.23.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.23.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.23.3 Pfizer Inc. Market Performance (2017-2022)
9.23.4 Recent Development
9.23.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Spinal Muscular Atrophy Treatment Market
1.2 Spinal Muscular Atrophy Treatment Market Segment by Type
1.2.1 Global Spinal Muscular Atrophy Treatment Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Spinal Muscular Atrophy Treatment Market Segment by Application
1.3.1 Spinal Muscular Atrophy Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Spinal Muscular Atrophy Treatment Market, Region Wise (2017-2027)
1.4.1 Global Spinal Muscular Atrophy Treatment Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.3 Europe Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.4 China Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.5 Japan Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.6 India Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.8 Latin America Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Spinal Muscular Atrophy Treatment Market Status and Prospect (2017-2027)
1.5 Global Market Size of Spinal Muscular Atrophy Treatment (2017-2027)
1.5.1 Global Spinal Muscular Atrophy Treatment Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Spinal Muscular Atrophy Treatment Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Spinal Muscular Atrophy Treatment Market
2 INDUSTRY OUTLOOK
2.1 Spinal Muscular Atrophy Treatment Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Spinal Muscular Atrophy Treatment Market Drivers Analysis
2.4 Spinal Muscular Atrophy Treatment Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Spinal Muscular Atrophy Treatment Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Spinal Muscular Atrophy Treatment Industry Development
3 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET LANDSCAPE BY PLAYER
3.1 Global Spinal Muscular Atrophy Treatment Sales Volume and Share by Player (2017-2022)
3.2 Global Spinal Muscular Atrophy Treatment Revenue and Market Share by Player (2017-2022)
3.3 Global Spinal Muscular Atrophy Treatment Average Price by Player (2017-2022)
3.4 Global Spinal Muscular Atrophy Treatment Gross Margin by Player (2017-2022)
3.5 Spinal Muscular Atrophy Treatment Market Competitive Situation and Trends
3.5.1 Spinal Muscular Atrophy Treatment Market Concentration Rate
3.5.2 Spinal Muscular Atrophy Treatment Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Spinal Muscular Atrophy Treatment Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Spinal Muscular Atrophy Treatment Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Spinal Muscular Atrophy Treatment Market Under COVID-19
4.5 Europe Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Spinal Muscular Atrophy Treatment Market Under COVID-19
4.6 China Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Spinal Muscular Atrophy Treatment Market Under COVID-19
4.7 Japan Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Spinal Muscular Atrophy Treatment Market Under COVID-19
4.8 India Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Spinal Muscular Atrophy Treatment Market Under COVID-19
4.9 Southeast Asia Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Spinal Muscular Atrophy Treatment Market Under COVID-19
4.10 Latin America Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Spinal Muscular Atrophy Treatment Market Under COVID-19
4.11 Middle East and Africa Spinal Muscular Atrophy Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Under COVID-19
5 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Spinal Muscular Atrophy Treatment Sales Volume and Market Share by Type (2017-2022)
5.2 Global Spinal Muscular Atrophy Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Spinal Muscular Atrophy Treatment Price by Type (2017-2022)
5.4 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue and Growth Rate of Oral (2017-2022)
5.4.2 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue and Growth Rate of Intrathecal (2017-2022)
6 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Global Spinal Muscular Atrophy Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Spinal Muscular Atrophy Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Gene Replacement Therapy (2017-2022)
6.3.2 Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Drug Therapy (2017-2022)
6.3.3 Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Other Procedures (2017-2022)
7 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET FORECAST (2022-2027)
7.1 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Spinal Muscular Atrophy Treatment Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Spinal Muscular Atrophy Treatment Price and Trend Forecast (2022-2027)
7.2 Global Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Spinal Muscular Atrophy Treatment Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Spinal Muscular Atrophy Treatment Revenue and Growth Rate of Oral (2022-2027)
7.3.2 Global Spinal Muscular Atrophy Treatment Revenue and Growth Rate of Intrathecal (2022-2027)
7.4 Global Spinal Muscular Atrophy Treatment Consumption Forecast by Application (2022-2027)
7.4.1 Global Spinal Muscular Atrophy Treatment Consumption Value and Growth Rate of Gene Replacement Therapy(2022-2027)
7.4.2 Global Spinal Muscular Atrophy Treatment Consumption Value and Growth Rate of Drug Therapy(2022-2027)
7.4.3 Global Spinal Muscular Atrophy Treatment Consumption Value and Growth Rate of Other Procedures(2022-2027)
7.5 Spinal Muscular Atrophy Treatment Market Forecast Under COVID-19
8 SPINAL MUSCULAR ATROPHY TREATMENT MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Spinal Muscular Atrophy Treatment Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Spinal Muscular Atrophy Treatment Analysis
8.6 Major Downstream Buyers of Spinal Muscular Atrophy Treatment Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Spinal Muscular Atrophy Treatment Industry
9 PLAYERS PROFILES
9.1 Catalyst Pharmaceuticals
9.1.1 Catalyst Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.1.3 Catalyst Pharmaceuticals Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 UW Health
9.2.1 UW Health Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.2.3 UW Health Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Cytokinetics, Inc.
9.3.1 Cytokinetics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.3.3 Cytokinetics, Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Genentech, Inc
9.4.1 Genentech, Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.4.3 Genentech, Inc Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Chugai Pharmaceutical
9.5.1 Chugai Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.5.3 Chugai Pharmaceutical Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Boehringer Ingelheim GmbH
9.6.1 Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.6.3 Boehringer Ingelheim GmbH Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 F. Hoffmann-La Roche AG
9.7.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.7.3 F. Hoffmann-La Roche AG Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 PTC Therapeutics
9.8.1 PTC Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.8.3 PTC Therapeutics Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Regeneron Pharmaceuticals, Inc.
9.9.1 Regeneron Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.9.3 Regeneron Pharmaceuticals, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Ionis Pharmaceuticals, Inc.
9.10.1 Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.10.3 Ionis Pharmaceuticals, Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 PerkinElmer, Inc.
9.11.1 PerkinElmer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.11.3 PerkinElmer, Inc. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Novo Nordisk A/S
9.12.1 Novo Nordisk A/S Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.12.3 Novo Nordisk A/S Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Novartis International AG
9.13.1 Novartis International AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.13.3 Novartis International AG Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Genzyme Corporation
9.14.1 Genzyme Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.14.3 Genzyme Corporation Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Salarius Pharmaceuticals, Inc.
9.15.1 Salarius Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.15.3 Salarius Pharmaceuticals, Inc. Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Astellas Pharma Inc.
9.16.1 Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.16.3 Astellas Pharma Inc. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Isis Pharmaceuticals, Inc.
9.17.1 Isis Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.17.3 Isis Pharmaceuticals, Inc. Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Cure SMA
9.18.1 Cure SMA Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.18.3 Cure SMA Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 AstraZeneca PLC
9.19.1 AstraZeneca PLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.19.3 AstraZeneca PLC Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Natera, Inc
9.20.1 Natera, Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.20.3 Natera, Inc Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 Biogen Inc.
9.21.1 Biogen Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.21.3 Biogen Inc. Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
9.22 Takeda Pharmaceutical Company Limited
9.22.1 Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.22.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.22.3 Takeda Pharmaceutical Company Limited Market Performance (2017-2022)
9.22.4 Recent Development
9.22.5 SWOT Analysis
9.23 Pfizer Inc.
9.23.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.23.2 Spinal Muscular Atrophy Treatment Product Profiles, Application and Specification
9.23.3 Pfizer Inc. Market Performance (2017-2022)
9.23.4 Recent Development
9.23.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Spinal Muscular Atrophy Treatment Product Picture
Table Global Spinal Muscular Atrophy Treatment Market Sales Volume and CAGR (%) Comparison by Type
Table Spinal Muscular Atrophy Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Spinal Muscular Atrophy Treatment Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Spinal Muscular Atrophy Treatment Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Spinal Muscular Atrophy Treatment Industry Development
Table Global Spinal Muscular Atrophy Treatment Sales Volume by Player (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Sales Volume Share by Player (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume Share by Player in 2021
Table Spinal Muscular Atrophy Treatment Revenue (Million USD) by Player (2017-2022)
Table Spinal Muscular Atrophy Treatment Revenue Market Share by Player (2017-2022)
Table Spinal Muscular Atrophy Treatment Price by Player (2017-2022)
Table Spinal Muscular Atrophy Treatment Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Spinal Muscular Atrophy Treatment Sales Volume, Region Wise (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume Market Share, Region Wise in 2021
Table Global Spinal Muscular Atrophy Treatment Revenue (Million USD), Region Wise (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Revenue Market Share, Region Wise in 2021
Table Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Sales Volume by Type (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Sales Volume Market Share by Type (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume Market Share by Type in 2021
Table Global Spinal Muscular Atrophy Treatment Revenue (Million USD) by Type (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type in 2021
Table Spinal Muscular Atrophy Treatment Price by Type (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate of Oral (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Oral (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate of Intrathecal (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Intrathecal (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption by Application (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption Market Share by Application (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption Revenue Market Share by Application (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Gene Replacement Therapy (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Drug Therapy (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Other Procedures (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Price and Trend Forecast (2022-2027)
Figure USA Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Spinal Muscular Atrophy Treatment Market Sales Volume Forecast, by Type
Table Global Spinal Muscular Atrophy Treatment Sales Volume Market Share Forecast, by Type
Table Global Spinal Muscular Atrophy Treatment Market Revenue (Million USD) Forecast, by Type
Table Global Spinal Muscular Atrophy Treatment Revenue Market Share Forecast, by Type
Table Global Spinal Muscular Atrophy Treatment Price Forecast, by Type
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Intrathecal (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Intrathecal (2022-2027)
Table Global Spinal Muscular Atrophy Treatment Market Consumption Forecast, by Application
Table Global Spinal Muscular Atrophy Treatment Consumption Market Share Forecast, by Application
Table Global Spinal Muscular Atrophy Treatment Market Revenue (Million USD) Forecast, by Application
Table Global Spinal Muscular Atrophy Treatment Revenue Market Share Forecast, by Application
Figure Global Spinal Muscular Atrophy Treatment Consumption Value (Million USD) and Growth Rate of Gene Replacement Therapy (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Consumption Value (Million USD) and Growth Rate of Drug Therapy (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Consumption Value (Million USD) and Growth Rate of Other Procedures (2022-2027)
Figure Spinal Muscular Atrophy Treatment Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Catalyst Pharmaceuticals Profile
Table Catalyst Pharmaceuticals Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Catalyst Pharmaceuticals Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Catalyst Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table UW Health Profile
Table UW Health Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure UW Health Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure UW Health Revenue (Million USD) Market Share 2017-2022
Table Cytokinetics, Inc. Profile
Table Cytokinetics, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cytokinetics, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Cytokinetics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Genentech, Inc Profile
Table Genentech, Inc Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genentech, Inc Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Genentech, Inc Revenue (Million USD) Market Share 2017-2022
Table Chugai Pharmaceutical Profile
Table Chugai Pharmaceutical Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Chugai Pharmaceutical Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Chugai Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim GmbH Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Boehringer Ingelheim GmbH Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche AG Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table PTC Therapeutics Profile
Table PTC Therapeutics Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PTC Therapeutics Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure PTC Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Regeneron Pharmaceuticals, Inc. Profile
Table Regeneron Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Regeneron Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Regeneron Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Ionis Pharmaceuticals, Inc. Profile
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Ionis Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table PerkinElmer, Inc. Profile
Table PerkinElmer, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PerkinElmer, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure PerkinElmer, Inc. Revenue (Million USD) Market Share 2017-2022
Table Novo Nordisk A/S Profile
Table Novo Nordisk A/S Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novo Nordisk A/S Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Novo Nordisk A/S Revenue (Million USD) Market Share 2017-2022
Table Novartis International AG Profile
Table Novartis International AG Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis International AG Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Novartis International AG Revenue (Million USD) Market Share 2017-2022
Table Genzyme Corporation Profile
Table Genzyme Corporation Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genzyme Corporation Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Genzyme Corporation Revenue (Million USD) Market Share 2017-2022
Table Salarius Pharmaceuticals, Inc. Profile
Table Salarius Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Salarius Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Salarius Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Astellas Pharma Inc. Profile
Table Astellas Pharma Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Astellas Pharma Inc. Revenue (Million USD) Market Share 2017-2022
Table Isis Pharmaceuticals, Inc. Profile
Table Isis Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Isis Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Isis Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Cure SMA Profile
Table Cure SMA Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cure SMA Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Cure SMA Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca PLC Profile
Table AstraZeneca PLC Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca PLC Spinal Muscular Atrophy Treatment Sales Volume an
Figure Spinal Muscular Atrophy Treatment Product Picture
Table Global Spinal Muscular Atrophy Treatment Market Sales Volume and CAGR (%) Comparison by Type
Table Spinal Muscular Atrophy Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Spinal Muscular Atrophy Treatment Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Spinal Muscular Atrophy Treatment Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Spinal Muscular Atrophy Treatment Industry Development
Table Global Spinal Muscular Atrophy Treatment Sales Volume by Player (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Sales Volume Share by Player (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume Share by Player in 2021
Table Spinal Muscular Atrophy Treatment Revenue (Million USD) by Player (2017-2022)
Table Spinal Muscular Atrophy Treatment Revenue Market Share by Player (2017-2022)
Table Spinal Muscular Atrophy Treatment Price by Player (2017-2022)
Table Spinal Muscular Atrophy Treatment Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Spinal Muscular Atrophy Treatment Sales Volume, Region Wise (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume Market Share, Region Wise in 2021
Table Global Spinal Muscular Atrophy Treatment Revenue (Million USD), Region Wise (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Revenue Market Share, Region Wise in 2021
Table Global Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Sales Volume by Type (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Sales Volume Market Share by Type (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume Market Share by Type in 2021
Table Global Spinal Muscular Atrophy Treatment Revenue (Million USD) by Type (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type in 2021
Table Spinal Muscular Atrophy Treatment Price by Type (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate of Oral (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Oral (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate of Intrathecal (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Intrathecal (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption by Application (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption Market Share by Application (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption Revenue Market Share by Application (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Gene Replacement Therapy (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Drug Therapy (2017-2022)
Table Global Spinal Muscular Atrophy Treatment Consumption and Growth Rate of Other Procedures (2017-2022)
Figure Global Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Price and Trend Forecast (2022-2027)
Figure USA Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Spinal Muscular Atrophy Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Spinal Muscular Atrophy Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Spinal Muscular Atrophy Treatment Market Sales Volume Forecast, by Type
Table Global Spinal Muscular Atrophy Treatment Sales Volume Market Share Forecast, by Type
Table Global Spinal Muscular Atrophy Treatment Market Revenue (Million USD) Forecast, by Type
Table Global Spinal Muscular Atrophy Treatment Revenue Market Share Forecast, by Type
Table Global Spinal Muscular Atrophy Treatment Price Forecast, by Type
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Intrathecal (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Revenue (Million USD) and Growth Rate of Intrathecal (2022-2027)
Table Global Spinal Muscular Atrophy Treatment Market Consumption Forecast, by Application
Table Global Spinal Muscular Atrophy Treatment Consumption Market Share Forecast, by Application
Table Global Spinal Muscular Atrophy Treatment Market Revenue (Million USD) Forecast, by Application
Table Global Spinal Muscular Atrophy Treatment Revenue Market Share Forecast, by Application
Figure Global Spinal Muscular Atrophy Treatment Consumption Value (Million USD) and Growth Rate of Gene Replacement Therapy (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Consumption Value (Million USD) and Growth Rate of Drug Therapy (2022-2027)
Figure Global Spinal Muscular Atrophy Treatment Consumption Value (Million USD) and Growth Rate of Other Procedures (2022-2027)
Figure Spinal Muscular Atrophy Treatment Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Catalyst Pharmaceuticals Profile
Table Catalyst Pharmaceuticals Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Catalyst Pharmaceuticals Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Catalyst Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table UW Health Profile
Table UW Health Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure UW Health Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure UW Health Revenue (Million USD) Market Share 2017-2022
Table Cytokinetics, Inc. Profile
Table Cytokinetics, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cytokinetics, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Cytokinetics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Genentech, Inc Profile
Table Genentech, Inc Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genentech, Inc Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Genentech, Inc Revenue (Million USD) Market Share 2017-2022
Table Chugai Pharmaceutical Profile
Table Chugai Pharmaceutical Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Chugai Pharmaceutical Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Chugai Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim GmbH Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Boehringer Ingelheim GmbH Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche AG Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table PTC Therapeutics Profile
Table PTC Therapeutics Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PTC Therapeutics Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure PTC Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Regeneron Pharmaceuticals, Inc. Profile
Table Regeneron Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Regeneron Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Regeneron Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Ionis Pharmaceuticals, Inc. Profile
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Ionis Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table PerkinElmer, Inc. Profile
Table PerkinElmer, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PerkinElmer, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure PerkinElmer, Inc. Revenue (Million USD) Market Share 2017-2022
Table Novo Nordisk A/S Profile
Table Novo Nordisk A/S Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novo Nordisk A/S Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Novo Nordisk A/S Revenue (Million USD) Market Share 2017-2022
Table Novartis International AG Profile
Table Novartis International AG Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis International AG Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Novartis International AG Revenue (Million USD) Market Share 2017-2022
Table Genzyme Corporation Profile
Table Genzyme Corporation Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genzyme Corporation Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Genzyme Corporation Revenue (Million USD) Market Share 2017-2022
Table Salarius Pharmaceuticals, Inc. Profile
Table Salarius Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Salarius Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Salarius Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Astellas Pharma Inc. Profile
Table Astellas Pharma Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Astellas Pharma Inc. Revenue (Million USD) Market Share 2017-2022
Table Isis Pharmaceuticals, Inc. Profile
Table Isis Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Isis Pharmaceuticals, Inc. Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Isis Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Cure SMA Profile
Table Cure SMA Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cure SMA Spinal Muscular Atrophy Treatment Sales Volume and Growth Rate
Figure Cure SMA Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca PLC Profile
Table AstraZeneca PLC Spinal Muscular Atrophy Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca PLC Spinal Muscular Atrophy Treatment Sales Volume an
